These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 1382453)
1. Possible toxicity associated with L-697,661 administration in a patient with AIDS. Harris PJ AIDS; 1992 Jun; 6(6):597-9. PubMed ID: 1382453 [No Abstract] [Full Text] [Related]
2. Foscarnet-induced penile ulceration. Torres T; Fernandes I; Sanches M; Selores M Acta Dermatovenerol Alp Pannonica Adriat; 2011; 20(1):39-40. PubMed ID: 21879205 [TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy for infection due to human immunodeficiency virus in children. Pizzo PA; Wilfert C Pediatr AIDS HIV Infect; 1994 Oct; 5(5):273-95. PubMed ID: 11361369 [No Abstract] [Full Text] [Related]
4. New AIDS drugs. Minn Med; 1991 Dec; 74(12):46. PubMed ID: 1724284 [No Abstract] [Full Text] [Related]
5. Human pharmacokinetics and tolerability of L-697,639, a non-nucleoside HIV-1 reverse transcriptase inhibitor. Van Hecken A; Depre M; De Lepeleire I; Laskin O; Au T; Woolf E; Yeh KC; De Schepper PJ Int J Clin Pharmacol Res; 1994; 14(2):45-50. PubMed ID: 7530697 [TBL] [Abstract][Full Text] [Related]
6. [A new AIDS drug in evaluation]. Fortschr Med; 1993 Aug; 111(24):12. PubMed ID: 7691696 [No Abstract] [Full Text] [Related]
7. Are we winning the battle against the human immunodeficiency virus. Sullivan AK; Nelson MR Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):486-8. PubMed ID: 10193449 [No Abstract] [Full Text] [Related]
9. [AIDS: the myth of Sisyphus]. Jaubert D Med Trop (Mars); 1999; 59(1):31-2. PubMed ID: 10472577 [No Abstract] [Full Text] [Related]
10. Confirmation for combination AIDS therapy. Science; 1995 Oct; 270(5233):33. PubMed ID: 7569948 [No Abstract] [Full Text] [Related]
11. Therapy other than reverse transcriptase inhibitors for HIV infection. Kaplan JC; Hirsch MS Clin Lab Med; 1994 Jun; 14(2):367-91. PubMed ID: 7523020 [TBL] [Abstract][Full Text] [Related]
12. [Development of new enzyme inhibitors for the treatment of AIDS[ ]. Herdewijn P Verh K Acad Geneeskd Belg; 1992; 54(2):139-53. PubMed ID: 1384252 [TBL] [Abstract][Full Text] [Related]
13. Future therapies in the management of critically ill AIDS patients. Torres RA; Franke-Ruta G; Barr MR Crit Care Clin; 1993 Jan; 9(1):153-76. PubMed ID: 7678542 [TBL] [Abstract][Full Text] [Related]
14. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development. de Clercq E Med Res Rev; 1996 Mar; 16(2):125-57. PubMed ID: 8656777 [No Abstract] [Full Text] [Related]
15. Strategies for antiviral therapy in AIDS. Mitsuya H; Broder S Nature; 1987 Feb 26-Mar 4; 325(6107):773-8. PubMed ID: 2434858 [TBL] [Abstract][Full Text] [Related]
16. 3TC approval may revive AZT's appeal. Vazquez E Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136 [TBL] [Abstract][Full Text] [Related]
17. Fewer brain lesions with AZT. Posit Aware; 1996; 7(1):7. PubMed ID: 11363133 [TBL] [Abstract][Full Text] [Related]
18. Some diagnostic and therapeutic issues in HIV infection. Handzel ZT Isr J Med Sci; 1993 Oct; 29(10 Suppl):24-5. PubMed ID: 7503965 [No Abstract] [Full Text] [Related]
19. [Treatment of HIV/AIDS. New possibilities result in new problems]. Nielsen JO Ugeskr Laeger; 1998 Jun; 160(23):3371. PubMed ID: 9627502 [No Abstract] [Full Text] [Related]
20. Antiretroviral drug treatment for HIV/AIDS. Goldschmidt RH; Moy A Am Fam Physician; 1996 Aug; 54(2):574-80, 587-8. PubMed ID: 8701838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]